Non-ownership Filings
| Final Results | Sep. 11, 2025 |
| Notice of Results | Sep. 04, 2025 |
| Strong Phase 2 data on iSCIB1+ in Melanoma | Jul. 22, 2025 |
| Share Option Exercise | Jul. 16, 2025 |
| Scancell initiates new arm in SCOPE Phase 2 study | Jun. 25, 2025 |
| Partnership with NHS Cancer Vaccine Launch Pad | Apr. 14, 2025 |
| Scancell to present at 2025 AACR Annual Meeting | Apr. 01, 2025 |
Ownership Update Filings
| Director Dealing | Sep. 16, 2025 |
| Director Dealing | Aug. 08, 2025 |
| Director/PDMR Shareholding | Aug. 04, 2025 |
| Director Dealing | May. 21, 2025 |
| Issue of share options | Feb. 20, 2025 |
| Holding(s) in Company | Oct. 24, 2024 |
| Issue of share options | May. 21, 2024 |